MusclePharm Schedules 2015 Second Quarter Financial Results

DENVER, CO -- (Marketwired) -- 08/03/15 -- MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the second quarter ended June 30, 2015 on Monday, August 10, 2015, following market close.

The Company will conduct a conference call the following morning, Tuesday, August 11, at 8:00 a.m. Eastern Time/5:00 a.m. Pacific Time.

2015 Second Quarter Conference Call Information

When: Tuesday, August 11 Time: 8:00 a.m. Eastern Time Phone: 877-407-9126 (domestic) 201-493-6751 (international)

A live webcast will be available online on MusclePharm's website at http://ir.musclepharmcorp.com/, where it will be archived for one year.

An audio replay of the conference call will be available through midnight August 18 by dialing 877-660-6853 from the U.S. or Canada, or 201-612-7415 from international locations, passcode 13581597.

About MusclePharm Corporation MusclePharm® is a scientifically driven, performance lifestyle company that currently develops, manufactures, markets and distributes branded nutritional supplements. The company offers a complete range of powders, capsules, tablets and gels. Its portfolio of recognized brands, including MusclePharm® Hybrid and Core Series, Arnold Schwarzenegger Series" and FitMiss", are marketed and sold in more than 120 countries and available in over 45,000 retail outlets globally. These clinically-proven and scientific nutritional supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit www.musclepharm.com.

Follow MusclePharm Corporation on Facebook, Twitter, and Instagram.

To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts

Investors:
Allyson Vento | Dana Gorman
The Abernathy MacGregor Group
(212) 371-5999
[email protected] | [email protected]

Media:
Becky Warren on behalf of MusclePharm
(916) 607-0129
[email protected]

Source: MusclePharm

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Citi downgrades Ryder Systems to neutral, raises price target
• Oportun Financial Corp (OPRT) PT Raised to $13 at B.Riley